StockTrendNews (STN) Exclusive:Keryx Biopharmaceuticals, Inc.
x
Twelve Months EBITDA Turns Positive for Keryx Biopharmaceuticals
Stock Quote:(NCM:KERX)
11/20/2009
2.67
-0.07
-2.55%
649,308
Twelve Months EBITDA Turns Positive for Keryx Biopharmaceuticals
Last
Price Change
% Chg
Volume
New York, NY, November 20, 2009-Ebitda News reports that EBITDA for Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) for its twelve months ended September 30, 2009 was a positive $7,596,000, compared with ... read full story
Stocks ended mixed on low volume, but the Dow and Nasdaq closed with gains for the 8th consecutive session. There were a number of economic releases today that showed another decline in jobless claims, very little inflation pressure and a pick-up in ... read full story
-0.07 
